36 results on '"Casanova, Ciro"'
Search Results
2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
3. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
4. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
5. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
6. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
7. The 7 Cardinal Sins of COPD in Spain
8. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
9. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
10. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
11. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
12. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
13. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
14. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
15. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
16. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
17. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
18. Prevalence and Determinants of COPD in Spain: EPISCAN II
19. Prevalence and Determinants of COPD in Spain: EPISCAN II
20. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol
21. Nuevo estudio sobre la prevalencia de la EPOC en España: resumen del protocolo EPISCAN II, 10 años después de EPISCAN
22. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
23. Características de los pacientes con EPOC tratados en neumología en España según grupos GOLD y fenotipos clínicos GesEPOC
24. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
25. Documento de expertos del uso de broncodilatadores inhalados en monoterapia en el tratamiento de la EPOC estable leve-moderada
26. Consensus on the Asthma–COPD Overlap (ACO) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)
27. Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Guía española de la EPOC (GesEPOC) y la Guía Española para el Manejo del Asma (GEMA)
28. Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease
29. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable
30. Analysis of Exposure and Respiratory Health Effects of Volcanic Eruption in the Canary Islands (ASHES). A SEPAR Study
31. [Translated article] ANTES Program: One Year on
32. ANTES: Un año después en la EPOC
33. Chronic Obstructive Pulmonary Disease in Non-Smokers
34. Enfermedad pulmonar obstructiva crónica de origen no tabáquico
35. WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
36. WITHDRAWN: Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.